Sathornsumetee, S., Desjardins, A., Vredenburgh, J. J., Rich, J. N., Gururangan, S., Janney, D. E., … Reardon, D. A. (2009). BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL. In NEURO-ONCOLOGY (Vol. 11, pp. 906–906). Yokohama, JAPAN: OXFORD UNIV PRESS INC.

Sathornsumetee, Sith, Annick Desjardins, James J. Vredenburgh, Jeremy N. Rich, Sridharan Gururangan, D. E. Janney, Allan H. Friedman, Henry S. Friedman, and David A. Reardon. “BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL.” In NEURO-ONCOLOGY, 11:906–906. OXFORD UNIV PRESS INC, 2009.

Sathornsumetee S, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Janney DE, et al. BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2009. p. 906–906.

Sathornsumetee, Sith, et al. “BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL.” NEURO-ONCOLOGY, vol. 11, no. 6, OXFORD UNIV PRESS INC, 2009, pp. 906–906.

Sathornsumetee S, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Janney DE, Friedman AH, Friedman HS, Reardon DA. BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2009. p. 906–906.